Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

204.93 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178
Open 204.93
Bid (Size) 200.01 (100)
Ask (Size) 208.97 (200)
Prev. Close 204.93
Today's Range 204.93 - 204.93
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 3.38%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
Shares of pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) climbed 3.3% in early trading on Monday, March 23, 2026, after the company issued a surprisingly robust financial outlook for the fiscal... 
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property
News headline image
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now ↗
AbbVie has strong financials, a great dividend, and its stock trades at a modest valuation. 
Via The Motley Fool
Topics ETFs Intellectual Property

Performance

YTD
-10.6%
-10.6%
1 Month
-10.7%
-10.7%
3 Month
-10.1%
-10.1%
6 Month
-7.9%
-7.9%
1 Year
-2.0%
-2.0%

More News

Read More
News headline image
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
Via MarketMinute
ABBVIE INC (NYSE:ABBV) Shows Strong Technical Setup for Potential Breakout ↗
Via Chartmill
News headline image
Best Healthcare Stocks to Buy After the Market Pullback ↗
Via The Motley Fool
News headline image
The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗
Via The Motley Fool
Topics Energy Intellectual Property
News headline image
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
Via MarketMinute
Topics ETFs Economy Intellectual Property
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
What's Going On With AbbVie Stock Today? ↗
Via Benzinga
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
My Top 3 Dividend Kings to Buy for March 2026 ↗
Via The Motley Fool
News headline image
My 5 Favorite Dividend Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Retirement
News headline image
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Market Downturn: 2 Stocks to Buy and Hold Through Any Storm ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Quiet Outperformance From an Overlooked Dividend ETF ↗
Via MarketBeat
News headline image
1 Momentum Stock to Consider Right Now and 2 We Ignore
Via StockStory
News headline image
These 3 Cash Flow Machines Provide Stability in Uncertain Markets ↗
Via MarketBeat
News headline image
AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Topics Stocks Supply Chain
News headline image
AbbVie: The Only Big Pharma Stock I'd Consider a Buy‑and‑Never‑Sell ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
Via Finterra
Topics Economy Initial Public Offering Retirement
News headline image
Why AbbVie Stock May Be the Ultimate Option for Dividend Investors ↗
Via The Motley Fool
Topics Economy
News headline image
Where Will AbbVie Be in 5 Years? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
Via MarketMinute
Topics Intellectual Property

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 204.93
When was AbbVie last traded?
The last trade of AbbVie was at 03/23/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>